Evidence map›Paper›PMID 39697387›Full record

ArticleJournal of pathology informatics2024

Leveraging deep learning for identification and segmentation of "CAF-1/p60-positive" nuclei in oral squamous cell carcinoma tissue samples.

Silvia Varricchio, Gennaro Ilardi, Daniela Russo, Rosa Maria Di Crescenzo, Angela Crispino, Stefania Staibano, Francesco Merolla

Abstract read
In one paragraph

Article in Journal of pathology informatics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Silvia VarricchioDepartment of Advanced Biomedical Sciences, Pathology Unit, University of Naples "Federico II", via S.Pansini, 5, Naples 80131, Italy.
Gennaro IlardiDepartment of Advanced Biomedical Sciences, Pathology Unit, University of Naples "Federico II", via S.Pansini, 5, Naples 80131, Italy.
Daniela RussoDepartment of Advanced Biomedical Sciences, Pathology Unit, University of Naples "Federico II", via S.Pansini, 5, Naples 80131, Italy.
Rosa Maria Di CrescenzoDepartment of Advanced Biomedical Sciences, Pathology Unit, University of Naples "Federico II", via S.Pansini, 5, Naples 80131, Italy.
Angela CrispinoDepartment of Advanced Biomedical Sciences, Pathology Unit, University of Naples "Federico II", via S.Pansini, 5, Naples 80131, Italy.
Stefania StaibanoDepartment of Advanced Biomedical Sciences, Pathology Unit, University of Naples "Federico II", via S.Pansini, 5, Naples 80131, Italy.
Francesco MerollaDepartment of Medicine and Health Sciences "V. Tiberio", University of Molise, via De Sanctis, Campobasso 86100, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the current study, we introduced a unique method for identifying and segmenting oral squamous cell carcinoma (OSCC) nuclei, concentrating on those predicted to have significant CAF-1/p60 protein expression. Our suggested model uses the StarDist architecture, a deep-learning framework designed for biomedical image segmentation tasks. The training dataset comprises painstakingly annotated masks created from tissue sections previously stained with hematoxylin and eosin (H&E) and then restained with immunohistochemistry (IHC) for p60 protein. Our algorithm uses subtle morphological and colorimetric H&E cellular characteristics to predict CAF-1/p60 IHC expression in OSCC nuclei. The StarDist-based architecture performs exceptionally well in localizing and segmenting H&E nuclei, previously identified by IHC-based ground truth. In summary, our innovative approach harnesses deep learning and multimodal information to advance the automated analysis of OSCC nuclei exhibiting specific protein expression patterns. This methodology holds promise for expediting accurate pathological assessment and gaining deeper insights into the role of CAF-1/p60 protein within the context of oral cancer progression.

Indexed as

CAF/p60ClassificationDeep learningDetectionH&EIHCOSCCQuPathSegmentationStardist

Identifiers

PMID39697387
PMCPMC11653155

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.